Ionis Pharmaceuticals Inc. buy marge
Start price
21.06.15
/
50%
€54.86
Target price
24.05.16
€70.00
Performance (%)
-45.15%
End price
24.05.16
€30.09
Summary
This prediction ended on 24.05.16 with a price of €30.09. The BUY prediction by marge for Ionis Pharmaceuticals Inc. performed very badly with a performance of -45.15%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | -2.965% | -2.965% | 104.824% | 96.867% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% | 51.204% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% | 93.733% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% | 51.187% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% | 65.291% |
Comments by marge for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Isis Pharmaceuticals
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)